ABSTRACT
Hyperacute rejection is very rare nowadays, because a crossmatch between the serum of the recipient and the lymphocytes of the donor is regularly performed before transplantation. The modern crossmatching techniques, such as flow cytometry crossmatch, are capable of revealing donor-relevant antibody specificities in the recipient which may not be detected by the standard complement-dependent cytotoxic technique (Cole et al., 2002).
